Shire PLC ADS (SHPG) News Nov 20, 2014, 5:17

New Post Public Reply Private Reply Replies (0) Message Board

Nov 21, 2014 at 1:13 AM

Shire PLC ADS (SHPG) News Nov 20, 2014, 5:17 p.m.
MarketWatch News on SHPG
Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
AbbVie raises outlook as profit, sales beat 8:26 a.m. Oct. 31, 2014 - MarketWatch.com
Mylan 3Q profit soars as revenue tops estimates 5:19 p.m. Oct. 30, 2014 - MarketWatch.com
Scuttled ‘inversion’ deals pile up in wake of Treasury rules 3:14 p.m. Oct. 27, 2014 - Robert Schroeder
Shire lifts outlook after strong sales growth 7:33 a.m. Oct. 24, 2014 - MarketWatch.com
Boeing, AT&T reports due Wednesday; Yahoo up late 6:48 p.m. Oct. 21, 2014 - Sue Chang
FTSE 100 climbs as oil stocks advance 12:03 p.m. Oct. 21, 2014 - Sara Sjolin
ASOS, Actelion, Akzo Nobel gain: Europe’s big stock movers 11:53 a.m. Oct. 21, 2014 - Sara Sjolin
3 stocks Ken Fisher likes 11:09 a.m. Oct. 21, 2014 - Insider Monkey
AbbVie formally scuttles deal to buy Shire 7:02 p.m. Oct. 20, 2014 - Russ Britt
AbbVie, Shire terminate proposed merger, inversion 5:40 p.m. Oct. 20, 2014 - Russ Britt
AbbVie will pay Shire $1.635 billion break fee 5:29 p.m. Oct. 20, 2014 - Russ Britt
AbbVie, Shire deal cancellation rules out inversion 5:28 p.m. Oct. 20, 2014 - Russ Britt
AbbVie, Shire terminate proposed merger 5:25 p.m. Oct. 20, 2014 - Russ Britt
Paulson & Co. pushes for Allergan merger with Shire: report 1:52 p.m. Oct. 20, 2014 - Sital S. Patel
Hedge funds just can’t catch a break this month 3:13 p.m. Oct. 16, 2014 - Ben Eisen
AbbVie board recommends shareholders vote against Shire deal 9:01 a.m. Oct. 16, 2014 - Shayndi Raice
U.S. stocks cut losses in harrowing, volatile session 4:49 p.m. Oct. 15, 2014 - Barbara Kollmeyer
Southwestern tops gainers; financial stocks among biggest losers 3:51 p.m. Oct. 15, 2014 - Sue Chang
The potential for 10 years of negative returns as fear takes hold 8:47 a.m. Oct. 15, 2014 - Shawn Langlois

Other News on SHPG
Shire to Relocate Employees Under One Shire Program - Analyst Blog 4:35 p.m. Nov. 20, 2014 - Zacks.com
What Does The U.S. Dollar Bull Market Mean For European Equities? 12:38 p.m. Nov. 20, 2014 - Seeking Alpha
3 Stocks Dragging The Drugs Industry Downward 12:16 p.m. Nov. 19, 2014 - TheStreet.com
Shire to Relocate Jobs to Massachusetts 10:36 a.m. Nov. 19, 2014 - The Wall Street Journal Interactive Edition
What The U.S. Dollar Bull Market Mean For The Global Equity Markets? 10:25 a.m. Nov. 19, 2014 - Seeking Alpha
Shire To Relocate Over 500 Jobs To Massachusetts 8:30 a.m. Nov. 19, 2014 - benzinga.com
Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook 1:00 a.m. Nov. 19, 2014 - Zacks.com
Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews 1:00 a.m. Nov. 19, 2014 - Zacks.com
David Tepper Buys 4 New Stocks in Q3 9:55 p.m. Nov. 18, 2014 - GuruFocus.com
AstraZeneca Bets Long Term on Cancer Drugs 10:53 a.m. Nov. 18, 2014 - The Wall Street Journal Interactive Edition
Deal Boom Feeds on Surging Stocks 7:33 p.m. Nov. 17, 2014 - The Wall Street Journal Interactive Edition
Cramer: Pfizer Deal With Merck Leaves AstraZeneca In the Cold 11:47 a.m. Nov. 17, 2014 - TheStreet.com
Amicus Therapeutics' Fabry disease drug candidate improves cardiac health marker 7:31 a.m. Nov. 17, 2014 - Seeking Alpha
Actavis Nears Deal to Acquire Allergan 7:23 p.m. Nov. 16, 2014 - The Wall Street Journal Interactive Edition
Amicus Drug Improves Marker of Heart Health in Fabry Patients 10:01 a.m. Nov. 15, 2014 - TheStreet.com
Expect More Specialty Pharma Deals 7:40 a.m. Nov. 14, 2014 - Barrons.com
EU Probing Apple Inc. (AAPL), Starbucks (SBUX) Tax Deals 6:06 a.m. Nov. 14, 2014 - InvestorPlace.com
Hedge Fund Tales - Or What Is Wrong With Merger Arbitrage 12:57 p.m. Nov. 13, 2014 - TheStreet.com
Sucampo (SCMP) Worth Watching: Stock Moves 7.4% Higher - Tale of the Tape 9:25 a.m. Nov. 13, 2014 - Zacks.com
Obama to Nominate Lazard Banker for a Top Treasury Post 6:10 p.m. Nov. 12, 2014 - The Wall Street Journal Interactive Edition

Press Releases on SHPG
Shire to Relocate Over 500 Jobs to Massachusetts 9:25 a.m. Nov. 19, 2014 - PR Newswire - PRF
Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms 7:00 a.m. Nov. 19, 2014 - PR Newswire - PRF
Collaboration, Breakthrough Therapy Designation, Clinical Trial Data, Voting Rights, and Financial Results - Research Reports on Johnson & Johnson, Merck, Amgen, Shire and HCA 8:50 a.m. Nov. 7, 2014 - PR Newswire - PRF
Shire to Participate at the Credit Suisse 2014 Global Healthcare Conference 7:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Critical Alerts For Apple, LightInTheBox, Time, 21st Century Fox and Shire Released By InvestorsObserver 9:31 a.m. Nov. 5, 2014 - PR Newswire - PRF
Cell Source CEO, Itamar Shimrat on his firm's transition from preclinical to human clinical trials 9:02 a.m. Nov. 5, 2014 - ACCESSWIRE
Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix 8:55 a.m. Nov. 4, 2014 - PR Newswire - PRF
Financial Results, Program Expansion, Product Launch, and Share Dealings - Research Reports on Merck, Johnson & Johnson, Amgen, Medtronic and Shire 9:15 a.m. Oct. 30, 2014 - PR Newswire - PRF
If You Purchased Shire plc American Depository Receipts ("ADRs"

During The Period Of June 20, 2014 And October 14, 2014 And Lost Money, Gardy & Notis, LLP Encourages You To Contact The Law Firm 8:38 a.m. Oct. 29, 2014 - PR Newswire - PRF
New Solution for Patients, Quarterly Financial Results, Clinical Study Initiation, Merger Updates, and Product Launch - Research Reports on CVS, Valeant, Regeneron, Allergan and Agilent 9:20 a.m. Oct. 23, 2014 - PR Newswire - PRF
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Shire plc: AbbVie Terminates Offer for Shire 5:22 p.m. Oct. 20, 2014 - PR Newswire - PRF
Announcement Of Termination Of Proposed AbbVie And Shire Transaction 5:12 p.m. Oct. 20, 2014 - PR Newswire - PRF
Acquisition Updates, Drug Approval, Drug Development Discontinuation, and Contract Update - Research Reports on AbbVie, Gilead, Pfizer, Lilly and Aetna 8:35 a.m. Oct. 20, 2014 - PR Newswire - PRF
Interim Chief Financial Officer James Bowling to Step Down 2:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Shire plc: Statement re: AbbVie's Withdrawal of Recommendation 4:31 a.m. Oct. 16, 2014 - PR Newswire - PRF
AbbVie Board Recommends Stockholders Vote Against Shire Transaction 11:53 p.m. Oct. 15, 2014 - PR Newswire - PRF
Shire plc: Statement re: Waiver of Notice of AbbVie's Board Meeting 2:32 p.m. Oct. 15, 2014 - PR Newswire - PRF
Shire plc: Statement re: AbbVie's Intention to Reconsider Recommendation 2:13 a.m. Oct. 15, 2014 - PR Newswire - PRF
Announcement Of Notice To Shire Of AbbVie Board Intention To Reconsider Recommendation 7:44 p.m. Oct. 14, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

PureHealth's Acid Reflux Solutions: An Investor's Insight

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

USPS Honors 150 Years of the U.S. Coast Guard Academy

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Larry Ellison's Moves Signal Confidence in Oracle's Future

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

D-Wave Faces Legal Questions After CFO Exit and Losses

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Silk Road Maritime Extends Its Global Reach in 2026

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...